The Board Of Regents Of The University Of Texas System
发明人:
Burton Dickey,Michael Tuvim,Scott Evans
申请号：
BRPI1009842
公开号：
BRPI1009842A2
申请日:
2010.03.25
申请国别(地区):
BR
年份:
2017
代理人:
摘要：
Embodiments of the invention are directed to methods of treating, inhibiting or attenuating a microbial infection in an individual who has or is at risk for developing such an infection, comprising the step of administering an effective amount of a TLR9 agonist and a TLR 2/6 agonist to the individual.
